- Home
- STRO vs PANL Comparison
STRO vs PANL Comparison
Compare STRO & PANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- PANL
- Stock Information
- Founded
- STRO 2003
- PANL 1996
- Country
- STRO United States
- PANL United States
- Employees
- STRO N/A
- PANL N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- PANL Marine Transportation
- Sector
- STRO Health Care
- PANL Consumer Discretionary
- Exchange
- STRO Nasdaq
- PANL Nasdaq
- Market Cap
- STRO 74.3M
- PANL 361.4M
- IPO Year
- STRO 2018
- PANL N/A
- Fundamental
- Price
- STRO $0.85
- PANL $5.58
- Analyst Decision
- STRO Hold
- PANL Strong Buy
- Analyst Count
- STRO 7
- PANL 1
- Target Price
- STRO $1.97
- PANL $9.00
- AVG Volume (30 Days)
- STRO 520.3K
- PANL 181.9K
- Earning Date
- STRO 11-12-2025
- PANL 11-11-2025
- Dividend Yield
- STRO N/A
- PANL 3.56%
- EPS Growth
- STRO N/A
- PANL N/A
- EPS
- STRO N/A
- PANL 0.16
- Revenue
- STRO $104,473,000.00
- PANL $579,781,169.00
- Revenue This Year
- STRO $65.48
- PANL $13.00
- Revenue Next Year
- STRO N/A
- PANL N/A
- P/E Ratio
- STRO N/A
- PANL $34.82
- Revenue Growth
- STRO N/A
- PANL 15.10
- 52 Week Low
- STRO $0.52
- PANL $3.93
- 52 Week High
- STRO $4.60
- PANL $7.50
- Technical
- Relative Strength Index (RSI)
- STRO 45.04
- PANL 62.23
- Support Level
- STRO $0.85
- PANL $5.44
- Resistance Level
- STRO $1.01
- PANL $5.69
- Average True Range (ATR)
- STRO 0.09
- PANL 0.15
- MACD
- STRO -0.01
- PANL 0.02
- Stochastic Oscillator
- STRO 5.30
- PANL 75.20
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About PANL Pangaea Logistics Solutions Ltd.
Pangaea Logistics Solutions Ltd and its subsidiaries provide seaborne drybulk logistics and transportation services. It transports various drybulk cargoes including grains, coal, iron, ore, pig, iron, hot briquetted iron, bauxite, alumina, cement clinker, dolomite, and limestone. The company provides ocean transportation services to clients utilizing an ocean-going fleet of motor vessels in the Handymax, Supramax, Ultramax, Panamax, and Post-Panamax segments. Its services include cargo loading, cargo discharge, vessel chartering, voyage planning, and technical vessel management. The company derives all of its revenues from contracts of affreightment, voyage charters and time charters. Geographically, it derives key revenue from the United States, followed by Canada, Germany, and others.